From the reliance on visual assessments to the lack of a consensus on instruments for assessment and monitoring, there are many causes for this subjectivity concern. However, there are a variety of tools and technologies available that can help make this process more objective.
As the nation’s principal authority overseeing the safety of food, drugs and cosmetics, the US Food and Drug Administration (FDA) requires manufacturers to provide proof of the safety and efficacy of their drugs before bringing them to market. This has … Read More
The rising cost of clinical research is leading more sponsors to outsource research and development (R&D) to clinical research organizations (CROs) to achieve efficiencies of scale that many companies can’t on their own. According to a 2016 Contract Pharma outsourcing … Read More
On May 25, 2018, the General Data Protection Regulation (GDPR), the most stringent data privacy law in the European Union’s (EU) history, went into effect. The new legal framework was designed to protect individuals in the EU from privacy and … Read More
Last year, the FDA approved dupilumab, the first biologic treatment for atopic dermatitis (AD), and a wave of similar products, now in clinical trials, followed. Biologics provide hope for those suffering from this chronic skin disease, also known as eczema, … Read More
Success of clinical trials is determined after the patient trials are over and the data has been analyzed. In order to eliminate bias and collect quality data which produces meaningful statistics toward study results, it is vital to conduct … Read More
The age of biologics in the treatment of dermatological indications is upon us. They hold promise for dermatological indications where treatments have been sparse. An increased demand for solutions to dermatological conditions where biologics might be effective can be attributed to several factors: increase in incidence of skin cancers, breakthroughs in biologics for psoriasis, and boomer generation demand for anti-aging products.
A History of the Perception of Dermatology In 2011, the American Academy of Dermatology (AAD) conducted a series of interviews using an independent research firm to determine the perception of the dermatology field among the senior leadership of non-dermatological physician … Read More
One third of the world’s population is impacted by dermatologic conditions inclusive of skin, nail and hair disorders. The emergence of biologic therapies for dermatologic conditions created a paradigm shift for these patients, especially those who have not responded well … Read More
Dermatology clinical trials are on the rise, especially in the indications of acne, atopic dermatitis, and psoriatic arthritis.1 Over the course of the past three years, the number of dermatology clinical trials has increased over 40%,2 despite an overall decline … Read More